Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 189

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem

Jenkins, P. J. · 2001 · Journal of Clinical Endocrinology & Metabolism

Abstract

Since the original description by Pierre Marie over a century ago, acromegaly has been known to be associated with an increased morbidity and mortality. Early epidemiological reviews suggested that this was due largely to cardiovascular, cerebrovascular, respiratory, and metabolic diseases. However, more recently, studies such as that by Ezzat and Melmed (1) have suggested that these patients currently are also at increased risk for cancer, particularly colorectal; some suggestions have been made that there is a risk of breast, prostate, and possibly hematological malignancies (2, 3) (Table 1). Some of the difficulty in determining the true incidence of cancer in this condition results from the relative rarity of acromegaly itself, which makes it difficult for individual centers to gather sufficient numbers of patients for statistical analysis. A further important factor is that it is only with improved treatment of the other complications that patients with acromegaly are now surviving long enough to reach the age of increased cancer risk. In the early series by Wright et al. (64) and Alexander et al. (65), approximately 50% of patients had died before the age of 60 yr; it is clearly inappropriate to use early reviews to draw conclusions relating to cancer risk in patients exposed to current improved practice because patients are now living much longer, and the development of malignancy in these patients appears to be age related. The establishment of the true prevalence of cancer in acromegaly requires current data and will become clearer with multicenter analysis, such as that of acromegaly registers being collated in the United Kingdom and U.S. Retrospective epidemiological reviews of occurrence of malignant disease in patients with acromegaly M, Male; F, female; NR, not recorded. P < 0.05. P < 0.01. P < 0.001. Retrospective epidemiological reviews of occurrence of malignant disease in patients with acromegaly M, Male; F, female; NR, not recorded. P < 0.05. P < 0.01. P < 0.001. Colorectal cancer. Of all cancers, evidence is strongest for an increased risk in acromegaly of colorectal cancer (Table 2), and this is now regarded by many researchers and consensus working groups as being a major complication of this disease (1, 2–7). The cancer surveillance program at St. Bartholomew’s Hospital was initiated after the publication of one of the earliest reports detailing an increased prevalence of colonic neoplasia by Ezzat and Melmed (8). In that study of 26 patients, 3 had colorectal cancer, and 8 had tubulo-villous adenomas. Of the 155 asymptomatic patients with acromegaly aged over 50 yr investigated at St. Bartholomew’s Hospital with full-length colonoscopic examination, 10 (6.5%) have been found to have adenocarcinoma. Although, in common with several other series, this study did not include asymptomatic matched controls, the relative risk can be assessed by comparison with published series of screened asymptomatic nonacromegalic patients (Table 3). These analyses give a relative risk of between 6.8- and 18.3-fold. That this increased risk is not restricted to our center is supported by grouping all of the prospective series of colonoscopic screening of patients with acromegaly: a total of 25 cancers have been detected in 681 patients (3.7%), compared with a rate of 0.5% among control subjects in those series with concurrent control groups (relative risk, 13.4; P < 0.00001). Even a recent study that reported no increased rate of colorectal neoplasia recorded cancers in 2.6% of asymptomatic patients with acromegaly (9). An increasing amount of data suggests that the prevalence of colorectal cancer is significantly increased in acromegaly, and in common with other researchers, we regard these patients as being at high risk of developing this malignancy (1, 3, 4, 6, 10). Retrospective and prospective studies of screening for colorectal neoplasia in patients with acromegaly Represents the current data from St. Bartholomew’s Hospital of patients aged over 50 yr. Retrospective and prospective studies of screening for colorectal neoplasia in patients with acromegaly Represents the current data from St. Bartholomew’s Hospital of patients aged over 50 yr. Relative risk of the prevalence of colorectal cancer (CRC) in patients with acromegaly determined by comparison of prevalence rates from St. Bartholomew’s Hospital and other published series to large scale screening studies of asymptomatic nonacromegalic subjects Ninety-five percent confidence intervals are in parentheses; P values are in brackets. Refs. 8, 9, 11–15, 17, 21–23, 69, and 70. Relative risk of the prevalence of colorectal cancer (CRC) in patients with acromegaly determined by comparison of prevalence rates from St. Bartholomew’s Hospital and other published series to large scale screening studies of asymptomatic nonacromegalic subjects Ninety-five percent confidence intervals are in parentheses; P values are in brackets. Refs. 8, 9, 11–15, 17, 21–23

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.86.7.2935

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 189

Metadata

Authors
Jenkins, P. J.
Venue
Journal of Clinical Endocrinology & Metabolism
Published
2001-07-01
Volume
86
Issue
7
Pages
2935-2941
ISSN
0021-972X (ISSN-L)
OpenAlex
W2077878271
Cited by
189
References
1
FWCI
6.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem. https://app.cochat.ai/papers/10.1210/jc.86.7.2935
The paper
Jenkins, P. J. (2001). CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem. Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.86.7.2935

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.